Halpin Valerie, Gupta Aditya
Legacy Good Samaritan Hospital, Portland, OR, USA.
BMJ Clin Evid. 2011 Dec 20;2011:0411.
Of people admitted to hospital for biliary tract disease, 20% have acute cholecystitis. Up to the age of 50 years, acute calculous cholecystitis is three times more common in women than in men, and about 1.5 times more common in women than in men thereafter. About 95% of people with acute cholecystitis have gallstones. Optimal therapy for acute cholecystitis, based on timing and severity of presentation, remains controversial.
We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for acute cholecystitis? We searched: Medline, Embase, The Cochrane Library, and other important databases up to April 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
We found 17 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
In this systematic review we present information relating to the effectiveness and safety of the following interventions: early cholecystectomy, laparoscopic cholecystectomy, minilaparoscopic cholecystectomy, observation alone, open cholecystectomy, and percutaneous cholecystostomy.
因胆道疾病入院的患者中,20%患有急性胆囊炎。在50岁之前,急性结石性胆囊炎在女性中的发病率是男性的三倍,50岁之后,女性的发病率约为男性的1.5倍。约95%的急性胆囊炎患者有胆结石。基于发病时间和严重程度的急性胆囊炎最佳治疗方法仍存在争议。
我们进行了一项系统评价,旨在回答以下临床问题:急性胆囊炎的治疗效果如何?我们检索了:截至2011年4月的医学期刊数据库(Medline)、荷兰医学文摘数据库(Embase)、考克兰图书馆及其他重要数据库(《临床证据》综述会定期更新;请查看我们的网站获取本综述的最新版本)。我们纳入了来自美国食品药品监督管理局(FDA)和英国药品及医疗保健产品监管局(MHRA)等相关组织的危害警示。
我们发现17项系统评价、随机对照试验或观察性研究符合我们的纳入标准。我们对干预措施的证据质量进行了GRADE评估。
在本系统评价中,我们提供了以下干预措施的有效性和安全性相关信息:早期胆囊切除术、腹腔镜胆囊切除术、迷你腹腔镜胆囊切除术、单纯观察、开腹胆囊切除术和经皮胆囊造瘘术。